PGEN - CIK 0001356090
The table below shows PRECIGEN, INC.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$87.83M | -$68.17M | -$66.93M | -$65.05M | -$55.77M | -$77.02M |
| Capital expenditure | $2.00M | $8.58M | $1.54M | $4.92M | $7.25M | $7.53M |
| Investing cash flow | -$1.53M | -$20.71M | -$3.09M | $226.42M | -$74.54M | $27.78M |
| Dividends paid | - | - | - | - | - |
PRECIGEN, INC. reported operating cash flow of -$87.83M for fiscal year 2025. That is down 28.8% from -$68.17M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$48.99M (FY 2016) to -$87.83M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $90.05M | $110.58M | $29.59M | -$155.29M | $121.19M | $32.70M |